Cryolipolysis / fat freezing

What controlled cooling does

Controlled cooling injures targeted fat cells, which the body gradually clears. A same-day photograph is not the final result; assessment takes months. Applicator shape, device identity and intended body site matter. Another machine or service marketed as fat freezing does not automatically share the same evidence, authorization or safety profile.

Section sources: ASPS · Cryolipolysis

Contouring differs from weight management

A smaller localized bulge may be a reasonable goal; substantial weight loss, removal of visceral fat and treatment of obesity are not. Weight and cardiometabolic health require a separate care pathway. Remaining fat cells can enlarge with weight gain, so a localized result does not guarantee lifelong contour stability. Define the cosmetic goal before choosing a package.

Section sources: AAD · Non-invasive fat removal: realistic expectations · FDA · Weight management is a separate clinical goal

When it may be unsuitable

Cold-sensitivity disorders, poor circulation and unusual reactions to cold need review. Disclose hernias, operations and abdominal-wall weakness; treatment near a hernia or weak area is inappropriate. Loose skin may remain after fat reduction and can change whether the result is acceptable. Pregnancy and breastfeeding should also be discussed before an elective body-contouring decision.

Section sources: FDA · Energy-device risks and device-specific contraindications · ASPS · Cryolipolysis · ASPS · Nonsurgical fat reduction

Comparing alternatives

Cryolipolysis avoids a surgical incision and usually allows earlier activity, but its effect is subtler and slower than liposuction. Heat-based, ultrasound and injection approaches are different technologies with different risks. Session requirements and possible correction should be assessed individually. If a large change is desired, a promise of surgical-equivalent results from one minimally invasive session deserves scrutiny.

Section sources: ASPS · Nonsurgical fat reduction compared with liposuction · ASPS · Nonsurgical fat reduction

Recovery and useful product categories

Redness, bruising, tenderness or numbness can occur. Obtain an activity plan, contact route and review date. A simple moisturizer can address dryness on intact, tolerant skin; a fat-burning cream does not establish additional contour benefit or treat deeper injury. Do not experiment with heat, extra ice, vigorous massage or active cosmetics over blisters, wounds or unusual pain.

Section sources: Prospective observational study · Cryolipolysis adverse-event follow-up (2025) · AAD · Choosing a moisturizer and avoiding irritation · Systematic review · Cryolipolysis adverse events (2020)

Paradoxical adipose hyperplasia: PAH

With PAH, treated fat becomes larger and firm instead of shrinking, sometimes outlining the applicator. It can appear months later; FDA describes reported onset two to five months after treatment. It does not normally disappear spontaneously and may require surgical correction. Do not dismiss it as ordinary weight gain or book repeat freezing before an appropriate assessment.

A 2025 review estimated pooled PAH incidence at approximately 0.22% of patients, with low-certainty evidence and inadequate follow-up in many studies. This is not your personal risk or a rate for every device. A Canadian multicentre cohort also suggests device- and treatment-era differences.

Section sources: FDA · Energy-device risks and device-specific contraindications · Systematic review · PAH incidence after cryolipolysis, 28 studies (2025) · Canadian multicentre cohort · PAH after 8,658 cryolipolysis cycles

Follow-up and warning signs

Cold injury, severe or increasing pain, blisters or wounds, new weakness around the mouth and prolonged numbness need prompt assessment. Use consistent lighting, posture and camera distance for follow-up photographs. Before paying, ask who evaluates complications or an unsatisfactory result and what additional costs might arise. Choosing no contour treatment remains a valid option.

Section sources: Systematic review · Cryolipolysis adverse events (2020) · AAD · Non-invasive fat removal: realistic expectations

Frequently asked questions

Related guides to explore

• Deoxycholic acid for submental fat
• Sclerotherapy for leg veins

Sources and context

Canadian sources take priority for regulatory context. FDA or other foreign information does not establish Canadian authorization for a product or use. A source-check date is distinct from publication date or independent clinical approval.

1. ASPS · Cryolipolysissociety · 2026-10-17
2. AAD · Non-invasive fat removal: realistic expectationssociety · 2026-10-17
3. FDA · Weight management is a separate clinical goalregulator · 2026-10-17
4. FDA · Energy-device risks and device-specific contraindicationsregulator · 2026-10-17
5. ASPS · Nonsurgical fat reductionsociety · 2026-10-17
6. ASPS · Nonsurgical fat reduction compared with liposuctionsociety · 2026-10-17
7. Prospective observational study · Cryolipolysis adverse-event follow-up (2025)research · 2026-10-17
8. AAD · Choosing a moisturizer and avoiding irritationsociety · 2026-10-17
9. Systematic review · Cryolipolysis adverse events (2020)review · 2026-10-17
10. Systematic review · PAH incidence after cryolipolysis, 28 studies (2025)review · 2026-10-17
11. Canadian multicentre cohort · PAH after 8,658 cryolipolysis cyclesresearch · 2026-10-17